Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
773.830.04%
QQQ
742.990.2%
BTC/USD
85770.360.9486%
DIA
519.720.01%
GLD
400.360.5%
TLT
81.830.04%

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) Stock Price, Quote, News & History

PBLAOTCEM
Trade with Public
Trade with Public
$1.11
At close: Mar 15, 5:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompare

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
-
Volume / Avg.
300.00 / 1.34K
Day Range
- - -
52 Wk Range
0.00 - 2.50
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

Recent Panbela Therapeutics Inc News

Top 4 Health Care Stocks That Are Preparing To Pump This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Avi Kapoor

What's Going On With Panbela Therapeutics Stock Today?

Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expecting approximately $9.0 million in gross proceeds.
Nabaparna Bhattacharya

Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to 15,529.84. The S&P 500 also rose, gaining, 0.19% to 4,900.27.
Avi Kapoor

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.
Avi Kapoor

Dow Edges Lower; Cardlytics Shares Jump

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday. The Dow traded down 0.04% to 38,093.41 while the NASDAQ rose 0.15% to 4,891.83. The S&P 500 also rose, gaining, 0.02% to 4,891.83.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-15.57M
Investing Cash Flow (TTM)
775.00K
Financing Cash Flow (TTM)
14.03M
Free Cash Flow (TTM)
-15.57M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-767.00K

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$6.31M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-310900.90%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$3.74

Company Debt

Total Debt
$6.39M
LT Debt
$3.19M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$142.00K
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-$1.00M

Key Statistics

Open
-
Close
-
Volume / Avg.
300.00 / 1.34K
Day Range
- - -
52 Wk Range
0.00 - 2.50
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) stock?

A

You can purchase shares of PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM:PBLA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) competitors?

A

There are no as such competitors for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..

Q

What is the forecast, or price target, for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) stock?

A

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. has a consensus price target of $25.00.

Q

What is the current price for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA)?

A

The stock price for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM: PBLA) is $0.0111 last updated September 21, 2026 at 2:40 PM EDT.

Q

Does PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) pay a dividend?

A

There are no upcoming dividends for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..

Q

When is PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM:PBLA) reporting earnings?

A

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. does not have any upcoming earnings scheduled.

Q

Is PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) going to split?

A

There is no upcoming split for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..

Q

What sector and industry does PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) operate in?

A

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved